Rahaman Shaik

Mr. Rahaman Shaik


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2025 in Clinical and Experimental Medicine
Verified
Journal Article
Open access
RSRahaman Shaik
Rahaman Shaik
SRSai Abhistika Royyala
Sai Abhistika Royyala
BIBhanu Inapanuri
Bhanu Inapanuri
ADAkshaya Durgam
Akshaya Durgam
HKHuda Khan
Huda Khan
AUAdeeb Unnisa
Adeeb Unnisa
Tumor-infiltrating lymphocyte (TIL) therapy represents an emerging and promising approach in the field of cancer immunotherapy, harnessing the body's own immune cells to target and eliminate cancer cells. This review provides an in-depth analysis of TIL therapy, focusing on its mechanisms, clinical applications, challenges, and future prospects. TILs, particularly CD8 + T cells, are isolated from a patient's tumor, expanded ex vivo, and reinfused to promote anti-tumor immunity. The success of TIL therapy has been demonstrated in various cancers, particularly melanoma, where it has led to durable responses and, in some cases, complete remission. However, significant challenges remain, including the heterogeneity of TIL populations, difficulties in large-scale expansion, and immune-related adverse events. We also explore current strategies aimed at overcoming these limitations, including genetic modification of TILs, combinatory approaches with checkpoint inhibitors, and optimization of tumor infiltration protocols. With ongoing research and technological advancements, TIL therapy holds substantial promise as a cornerstone of personalized cancer treatment. This review synthesizes the current landscape of TIL therapy, providing insights into its clinical efficacy, potential for broader application, and the future of cancer immunotherapy.

12 April 2025 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
RSRahaman Shaik
Rahaman Shaik
SCSai Manasa Chittepu
Sai Manasa Chittepu
MTMeghana Tarapatla
Meghana Tarapatla
FBFathima Begum
Fathima Begum
SVSrujan Vempati
Srujan Vempati
ARAbhistika Royyala
Abhistika Royyala

24 January 2026 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
RSRahaman Shaik
Rahaman Shaik
MVMounika Varikuppala
Mounika Varikuppala
SBSathvika Badampudi
Sathvika Badampudi
AJAsra Jabeen
Asra Jabeen
MHMohammed Anas Hamzah
Mohammed Anas Hamzah
SAShaik Azeeza
Shaik Azeeza

19 November 2025 in Therapeutic Innovation & Regulatory Science
Verified
Journal Article
Closed access
PDF file
RSRahaman Shaik
Rahaman Shaik
SLSai Geethika Laddika
Sai Geethika Laddika
MUMadiha Unnisa
Madiha Unnisa
AHAnas Hamza
Anas Hamza
SBShireen Begum
Shireen Begum
SSSyeda Fatima Sarwar
Syeda Fatima Sarwar

11 June 2025 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
RSRahaman Shaik
Rahaman Shaik
BYBilla Yashaswi
Billa Yashaswi
MAMeravath Anjali
Meravath Anjali
SSSana Syeda
Sana Syeda
HKHuda Khan
Huda Khan

24 January 2026 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
RSRahaman Shaik
Rahaman Shaik
SRSai Abhistika Royyala
Sai Abhistika Royyala
BIBhanu Inapanuri
Bhanu Inapanuri
SSSyeda Fatima Sarwar
Syeda Fatima Sarwar
SMShaheen Mahira
Shaheen Mahira
SAShaik Azeeza
Shaik Azeeza